About Ensysce Biosciences, Inc. - Common Stock (ENSC)
Ensysce Biosciences Inc is a biotechnology company focused on developing innovative solutions for the treatment of pain while minimizing the risk of addiction associated with opioid medications. The company utilizes its proprietary drug delivery platforms to create products that can enhance the therapeutic effects of existing pain medications and reduce their potential for misuse. Through advanced research and development, Ensysce aims to address the growing public health crisis surrounding opioid overuse by providing safer and more effective alternatives for pain management. Read More
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings (NASDAQ:ADGM) stock
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million. TransCode Therapeutics (NASDAQ:RNAZ)
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Rapid Dose Therapeutics (CSE: DOSE; OTCQB: RDTCF ), a biotechnology and drug delivery innovation company, is accelerating clinical validation of its proprietary QuickStrip™ oral thin film delivery system through expanded cannabinoid research and a high-profile study supported by the National Football League (NFL) .
